Insmed - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsInsmed

Insmed(INSM)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Arikayce	Amikacin	2018-09-28	2024-2035	Respiratory tract infections , Urinary tract infections , Bacterial infections , Intraabdominal infections , Pseudomonas infections , Infectious skin diseases , Escherichia coli infections , Soft tissue infections , Surgical wound infection , Staphylococcal infections , Burns , Endocarditis , Central nervous system infections , Proteus infections , Infectious bone diseases , Acinetobacter infections , Klebsiella infections , Mycobacterium infections , Serratia infections
Iplex	Mecasermin rinfabate	2005-12-12		—

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

,

obstructive lung diseases

,

pneumocystis pneumonia

,

,

respiratory aspiration

,

urinary bladder neoplasms

,

urologic surgical procedures

,

nontuberculous mycobacteria

,

abdominal abscess

,

,

extracorporeal membrane oxygenation

,

cystic fibrosis

,

nontuberculous mycobacterium infections

,

mycobacterium infections

,

bacterial pneumonia

,

,

mycobacterium avium-intracellulare infection

,

,

pseudomonas infections

,

persistent infection

,

,

,

respiratory tract infections

,

chronic obstructive pulmonary disease

,

,

respiratory tract diseases

,

,

cross infection

,

,

,

disease progression

,

hematopoietic stem cell transplantation

,

bacterial infections and mycoses

,

gram-positive bacterial infections

,

actinomycetales infections

,

,

,

,

ventilator-associated pneumonia

,

communicable diseases

,

,

urinary tract infections

,

,

,

multidrug-resistant tuberculosis

,

,

febrile neutropenia

,

bacterial infections

,

healthcare-associated pneumonia

,

,

critical illness

,

,

intraabdominal infections

,

,

bacterial meningitis

,

,

,

hematologic neoplasms

,

catheterization

,

klebsiella infections

,

liver cirrhosis

,

,

hepatic encephalopathy

,

escherichia coli infections

,

mycobacterium abscessus

,

,

pharmacokinetics

,

,

,

gram-negative bacterial infections

,

neonatal sepsis

,

,

chronic bronchitis

,

,

disease susceptibility

,

endophthalmitis

,

cerebral hemorrhage

,

subarachnoid hemorrhage

,

drug monitoring

,

systemic inflammatory response syndrome

,

,

chronic renal insufficiency

,

,

kidney diseases

,

migraine disorders

,

,

,

,

,

,

,

,

hyperaldosteronism

,

pulmonary arterial hypertension

,

,

sleep initiation and maintenance disorders

,

cardiac arrhythmias

,

methicillin-resistant staphylococcus aureus

,

,

,

staphylococcal infections

,

,

,

general anesthesia

,

,

,

,

,

central nervous system infections

,

neuromuscular blockade

,

,

,

cytomegalovirus retinitis

,

adenoviridae infections

,

port-wine stain

,

,

,

capillary hemangioma

,

,

bipolar disorder

,

autistic disorder

,

,

,

treatment-resistant schizophrenia

,

potassium deficiency

,

multiple drug resistance

,

,

respiration disorders

,

,

respiratory insufficiency

,

bronchial spasm

,

,

acquired immunodeficiency syndrome

,

pulmonary tuberculosis

,

aids-related opportunistic infections

,

,

asphyxia neonatorum

,

hematologic diseases

,

respiratory syncytial viruses

,

,

enhanced recovery after surgery

,

,

Mecasermin rinfabate

myotonic dystrophy

,

,

healthy volunteers/patients

,

renal insufficiency

,

,

hepatic insufficiency

,

,

cystic fibrosis

,

,

hidradenitis suppurativa

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use